Jan 5 |
Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds
|
Jan 5 |
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
|
Jan 4 |
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jan 4 |
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
|
Jan 2 |
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
|
Dec 1 |
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
|
Nov 30 |
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|
Nov 29 |
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Nov 29 |
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
|
Nov 14 |
Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32
|